Hudson Bay Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-30,000
| Closed | -$827K | – | 751 |
|
2023
Q4 | $827K | Hold |
30,000
| – | – | 0.01% | 458 |
|
2023
Q3 | $672K | Buy |
+30,000
| New | +$672K | 0.01% | 509 |
|
2023
Q1 | – | Sell |
-42,500
| Closed | -$1.62M | – | 906 |
|
2022
Q4 | $1.62M | Sell |
42,500
-17,500
| -29% | -$668K | 0.02% | 595 |
|
2022
Q3 | $3.01M | Sell |
60,000
-15,000
| -20% | -$753K | 0.03% | 567 |
|
2022
Q2 | $3.01M | Hold |
75,000
| – | – | 0.02% | 604 |
|
2022
Q1 | $2.8M | Hold |
75,000
| – | – | 0.04% | 591 |
|
2021
Q4 | $2.99M | Sell |
75,000
-15,000
| -17% | -$597K | 0.03% | 527 |
|
2021
Q3 | $3.35M | Buy |
90,000
+30,000
| +50% | +$1.12M | 0.05% | 475 |
|
2021
Q2 | $2.54M | Buy |
+60,000
| New | +$2.54M | 0.03% | 539 |
|
2019
Q4 | – | Sell |
-30,000
| Closed | -$1.02M | – | 468 |
|
2019
Q3 | $1.02M | Buy |
30,000
+25,000
| +500% | +$846K | 0.03% | 293 |
|
2019
Q2 | $225K | Sell |
5,000
-20,000
| -80% | -$900K | 0.01% | 333 |
|
2019
Q1 | $941K | Buy |
+25,000
| New | +$941K | 0.01% | 332 |
|
2018
Q2 | – | Sell |
-50,000
| Closed | -$1.35M | – | 596 |
|
2018
Q1 | $1.35M | Sell |
50,000
-10,000
| -17% | -$271K | 0.03% | 288 |
|
2017
Q4 | $1M | Buy |
+60,000
| New | +$1M | 0.02% | 279 |
|